AMSTERDAM, February 6, 2018 /PRNewswire/ --
Outcomes seek to explore how machine learning and data analytics can guide researchers
Elsevier, the information analytics business specializing in science and health, and Euretos announced a joint pilot to enrich scientific publications with hypotheses that
"The Next Research discussion group is a fantastic new initiative that we're very excited to be a part of at IJBCB. An open platform to discuss the 'big picture' questions emerging from different fields is a great way to get the global research community thinking collectively about important themes and new directions," said Dr. Maddy Parsons, Editor-in-Chief of IJBCB. "It also offers an opportunity for exchanging ideas across disciplines and opening the door to new innovative ways to tackle key emerging problems. We encourage researchers at every level to get involved in the discussion and hopefully some exciting ideas will emerge!"
The hypothesis that was created using the Euretos AI Platform investigates the interactions between ubiquitin-proteasome system and autophagy and is available from the BioRN site.
"The Euretos AI platform demonstrates the value of using Big Data analytics to accelerate multi omics research. Making these capabilities part of hypothesis generation within the scientific discourse, would raise its potential impact significantly," said Arie Baak of Euretos.
The pilot includes the following steps:
"At Elsevier, we are excited to explore how cutting-edge technology can be combined with expert input from Editors and other researchers to support the research dialogue", said Robbertjan Kalff, Vice President Online Communities at Elsevier.
Read more about the collaboration on Elsevier Connect.
Euretos, founded in 2012 in the Netherlands, provides an AI platform mainly used by pre-clinical researchers for in-silico discovery and validation of targets and biomarkers. World-leading pharma, biotech and academic institutions use it to accelerate their multi omics research. By integrating over 200 public databases, the platform provides the largest single environment in which the latest multi omics data is interlinked to literature, experimental and clinical evidence. Euretos puts the power of bioinformatics in the hands of the researcher via an easy-to-use search engine and embedded analytics functions. This enables researchers to discover and evaluate how molecular mechanisms influence cell and tissue functions, and in turn mediate phenotypes and disease pathology.
About The International Journal of Biochemistry and Cell Biology
IJBCB publishes original research articles, invited reviews and in-focus articles in all areas of cell and molecular biology and biomedical research.
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, Scival, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
Media contact Harald Boersma, Global Communications Elsevier +31-20-485-2736 firstname.lastname@example.org
Subscribe to our Free Newsletters!
Fennel seeds are a must-have in almost every Indian kitchen due to its health quotient. Here are a ...
True vertigo is a severe form of dizziness that is a movement hallucination. Try out some of these ...
Oxidative stress is a form of injury to body tissues due to increase in free radicals. If the ...View All